Analysts expect Edwards Lifesciences to report an earnings per share (EPS) of $0.65.
Investors in Edwards Lifesciences are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
The company's EPS beat by $0.01 in the last quarter, leading to a 31.34% drop in the share price on the following day.
Here's a look at Edwards Lifesciences's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
0.69
0.64
0.64
0.59
EPS Actual
0.70
0.66
0.64
0.59
Price Change %
-31.0%
-2.0%
-2.0%
-8.0%
Edwards Lifesciences Share Price Analysis
Shares of Edwards Lifesciences were trading at $69.24 as of October 22. Over the last 52-week period, shares are up 11.8%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analyst Insights on Edwards Lifesciences
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Edwards Lifesciences.
A total of 26 analyst ratings have been received for Edwards ...
